West nile virus future or investigational therapies

Revision as of 16:45, 11 September 2014 by Alejandro Lemor (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

Ribavirin and interferon alfa-2b are currently being studied for the treatment of west nile virus CNS infection, as both drugs have shown benefit in in vitro studies.

Future or Investigational Therapies

Vaccine

Medications

  • Ribavirin has been used in cases of west nile virus CNS involvement, as it has demonstrated inhibition of the virus in human neural cells in vitro.[2][3]
  • Interferon alfa-2b has also shown benefit in in vitro studies against west nile virus CNS infection.[4]
  • Further studies need to be done to determine the efficacy and safety of ribavirin and interferon alfa-2b in west nile virus infection.

References

  1. Brandler, Samantha; Tangy, Frederic (2013). "Vaccines in Development against West Nile Virus". Viruses. 5 (10): 2384–2409. doi:10.3390/v5102384. ISSN 1999-4915.
  2. I. Jordan, T. Briese, N. Fischer, J. Y. Lau & W. I. Lipkin (2000). "Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells". The Journal of infectious diseases. 182 (4): 1214–1217. doi:10.1086/315847. PMID 10979920. Unknown parameter |month= ignored (help)
  3. S. Ia Loginova, S. V. Borisevich, Iu A. Pashchenko & V. P. Bondarev (2009). "[Ribavirin prophylaxis and therapy of experimental West Nile fever]". [[Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] / Ministerstvo meditsinskoi i mikrobiologicheskoi promyshlennosti SSSR]]. 54 (11–12): 17–20. PMID 20583562.
  4. Anderson, John F. (2002). "Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro". Emerging Infectious Diseases. 8 (1): 107–108. doi:10.3201/eid0801.010252. ISSN 1080-6040.


Template:WS